Search hospitals > Pennsylvania > Philadelphia
Thomas Jefferson University
Claim this profilePhiladelphia, Pennsylvania 19107
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Tumors
Conducts research for Prostate Cancer
Conducts research for Lung Cancer
749 reported clinical trials
137 medical researchers
Summary
Thomas Jefferson University is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Tumors, Prostate Cancer, Lung Cancer and other specialties. Thomas Jefferson University is involved with conducting 749 clinical trials across 1,261 conditions. There are 137 research doctors associated with this hospital, such as Sarah W. Gordon, DO, Mark Shahin, MD, Babar Bashir, and Usama Gergis, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Sarah W. Gordon, DOVirginia Commonwealth University/Massey Cancer Center8 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
26 reported clinical trials
54 drugs studied
Mark Shahin, MDAsplundh Cancer Pavilion1 year of reported clinical research
Studies Cancer
Studies Ovarian Cancer
18 reported clinical trials
60 drugs studied
Babar BashirThomas Jefferson University Hospital1 year of reported clinical research
Studies Solid Tumors
Studies Tumors
14 reported clinical trials
28 drugs studied
Usama Gergis, MDThomas Jefferson University7 years of reported clinical research
Studies Lymphoma
Studies Tumors
13 reported clinical trials
29 drugs studied
Clinical Trials running at Thomas Jefferson University
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Prostate Cancer
Multiple Sclerosis
Bladder Cancer
Cancer
Plasma Cell Neoplasms
Iron-Deficiency Anemia
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Thomas Jefferson University?
Thomas Jefferson University is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Tumors, Prostate Cancer, Lung Cancer and other specialties. Thomas Jefferson University is involved with conducting 749 clinical trials across 1,261 conditions. There are 137 research doctors associated with this hospital, such as Sarah W. Gordon, DO, Mark Shahin, MD, Babar Bashir, and Usama Gergis, MD.
Where is Thomas Jefferson University located?
To reach Thomas Jefferson University Hospital in Philadelphia, take I-95 South to Exit 22 (Central Philadelphia/Independence Hall/Callowhill Street), then turn right onto Callowhill Street. The hospital is situated between 8th and 11th Streets, and Chestnut and Locust Streets.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Thomas Jefferson University Hospital, contact the Financial Services Office at (360) 385-2271, available from 9:00 am to 4:30 pm. They offer options such as charity care, sliding fee scale, prompt pay discount, and payment plans. For general financial support, reach Thomas Jefferson Enterprise Finance at (360) 385-2200 ext. 2267.
What insurance does Thomas Jefferson University accept?
**Thomas Jefferson University Insurance and Benefits Overview**
**For Students:**
- Mandatory insurance through United Healthcare, managed by University Health Plans, is required unless waived by students with comparable insurance. It covers comprehensive healthcare services in the Jefferson campus area.
**For Employees:**
- Medical Plans: Offers Platinum PPO, Gold PPO, and Silver PPO plans, all including prescription coverage. Complete freedom of choice of providers with the lowest out-of-pocket costs within the Jefferson Network.
- Vision Insurance: Covers eye exams, lenses, frames, and contacts with lowest costs at participating providers and partial reimbursement for out-of-network services.
- Dental Plans: Offers one DMO and two PPO plans covering preventive, basic, restorative, and major services. The Platinum plan includes orthodontia.
- Life and Disability Insurance: Provides basic life, AD&D, and business travel accident insurance. Offers supplemental options for employees and their families. Basic short-term and long-term disability coverage is available for full-time employees.
- Flexible Spending Accounts (FSA): Two types of FSAs are available for pre-tax contributions towards qualified medical, dental, vision expenses, and dependent care services.
**For Patients and Guests:**
- Accepts various insurance plans including AARP Medicare, Aetna, Ambetter, AmeriHealth, Cigna, Geisinger, Highmark, Horizon, Independence, Keystone, Medicare, Personal Choice, QualCare, Tricare, United Healthcare, and more.
What awards or recognition has Thomas Jefferson University received?
Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, is renowned for its research and care, having been awarded over $201 million in sponsored research awards. This includes $86,135,132 in funding from the National Institutes of Health (NIH). The hospital boasts 1,281 active clinical studies and holds full accreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP), ensuring the highest standards and protections for research participants.